Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease - Implications for clinical practice

被引:23
作者
Di Castelnuovo, A [1 ]
de Gaetano, G [1 ]
Donati, MB [1 ]
Iacoviello, L [1 ]
机构
[1] Catholic Univ, Lab Genet & Environm Epidemiol, Res Labs, Ctr High Technol Res & Educ Biomed Sci, I-86100 Campobasso, Italy
关键词
D O I
10.2165/00129785-200505020-00002
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Membrane glycoprotein (GP) IIb/IIIa plays a major role in platelet function; indeed it enables stimulated platelets to bind fibrinogen and related adhesive proteins, a process that is considered key in the development of thrombosis. The gene encoding GPIIIa (ITGB3, also known as GP3A) shows a common platelet antigen polymorphism [PL(A1)/PL(A2); expressed by alleles ITGB3*001 and ITGB3*002] that was variably associated with vascular disease. In 1996, the presence of the PL(A2) allele (ITGB3*001) was first reported to increase the risk of coronary heart disease. Shortly after, the interest in this study was increased by the publication of a case report on the death from myocardial infarction of an Olympic athlete who was found to be homozygous for the PL(A2) allele. Overviews of the published studies on the PL(A1)/PL(A2) polymorphism and coronary risk suggest an influence of the PL(A2) allele on the clinical phenotype and the interaction with other environmental factors. In particular, the strongest effect of the ITGB3 PL(A2) allele was expressed on the risk of occlusion after revascularization procedures, mainly after stent implantation, a condition in which platelet activation is more important as compared with other stenotic mechanisms. In the future, the identification of patients who are particularly responsive to GPIIb/IIIa antagonist therapy (e.g. those with the PL(A2) allele) might help to improve the treatment efficacy in this relatively small population. In a mechanism possibly unrelated to its effect on platelet reactivity to aggregating stimuli, the presence of the PL(A2) allele might influence the antiaggregatory effect of platelet inhibitory drugs such as aspirin (acetylsalicylic acid), clopidogrel, and GPIIb/IIIa antagonists. Although interesting, current data does not yet have direct clinical implications for patient risk identification and drug therapy tailoring. Larger studies are necessary to define the role of the PL(A2) allele in more homogeneous groups where platelet GPIIb/IIIa activation might be particularly relevant.
引用
收藏
页码:93 / 99
页数:7
相关论文
共 50 条
[1]   Role of platelet glycoprotein pLA1/A2 polymorphism in restenosis after percutaneous transluminal coronary angioplasty [J].
Abbate, R ;
Marcucci, R ;
Camacho-Vanegas, O ;
Pepe, G ;
Gori, AM ;
Capanni, M ;
Simonetti, I ;
Prisco, D ;
Gensini, GF .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (04) :524-+
[2]   Platelet PlA2 allele and incidence of coronary heart disease -: Results from the atherosclerosis risk in communities (ARIC) study [J].
Aleksic, N ;
Juneja, H ;
Folsom, AR ;
Ahn, C ;
Boerwinkle, E ;
Chambless, LE ;
Wu, KK .
CIRCULATION, 2000, 102 (16) :1901-1905
[3]   The glycoprotein Ib-IX-V complex in platelet adhesion and signaling [J].
Andrews, RK ;
Shen, Y ;
Gardiner, EE ;
Dong, JF ;
López, JA ;
Berndt, MC .
THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) :357-364
[4]   Defective platelet response to arachidonic acid and thromboxane A2 in subjects with PlA2 polymorphism of β3 subunit (glycoprotein IIIa) [J].
Andrioli, G ;
Minuz, P ;
Solero, P ;
Pincelli, S ;
Ortolani, R ;
Lussignoli, S ;
Bellavite, P .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (04) :911-918
[5]   Platelet glycoprotein IIb/IIIa PlA2/PlA2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men -: The Copenhagen City Heart Study [J].
Bojesen, SE ;
Juul, K ;
Schnohr, P ;
Tybjærg-Hansen, A ;
Nordestgaard, BG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (04) :661-667
[6]  
Bray PF, 1999, THROMB HAEMOSTASIS, V82, P337
[7]   The platelet PlA2 and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction [J].
Bray, PF ;
Cannon, CP ;
Goldschmidt-Clermont, P ;
Moyé, LA ;
Pfeffer, MA ;
Sacks, FM ;
Braunwald, E .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (04) :347-352
[8]   A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart disease [J].
Burr, D ;
Doss, H ;
Cooke, GE ;
Goldschmidt-Clermont, PJ .
STATISTICS IN MEDICINE, 2003, 22 (10) :1741-1760
[9]  
Coller BS, 1999, THROMB HAEMOSTASIS, V82, P326
[10]  
COLLER BS, 1994, SEMIN HEMATOL, V31, P301